119th Congress · introduced in the House · Apr 7, 2025
CBO Scoring Accountability Act
Official title from Congress.gov
Latest action (Apr 7, 2025): Referred to the House Committee on the Budget.
View on Congress.govPolicy area: Economics and Public Finance
Congressional Research Service summary, version: Introduced in House (Apr 7, 2025)
CBO Scoring Accountability Act
This bill requires the Congressional Budget Office (CBO) to provide additional cost estimates and reports regarding major legislation that has been enacted into law.
Under the bill, major legislation is any bill or joint resolution that would be projected to result in outlays of mandatory spending or receipts of federal revenue equal to or greater than 0.25% of the current projected gross domestic product of the United States for that year.
For the first 10 years after major legislation has been enacted into law, the bill requires CBO to annually prepare and make publicly available an analysis of the results of carrying out the provisions of the legislation. The analysis must include
• an estimate of the costs and the change in federal revenue as a result of the legislation,
• a comparison of the current and previous estimates of the costs and change in revenue, and
• any applicable updates to the estimates.
The bill also requires CBO to submit reports to Congress that explain any discrepancy between the actual and estimated costs and change in revenue that is greater than or equal to 10%.
Show less of the summaryIncludes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on the Budget.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
1 citation.
ORCHARD THERAPEUTICS NORTH AMERICA · lobbying firm or registrant: ORCHARD THERAPEUTICS NORTH AMERICA
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 18, 2025 · issue area: Medicare/Medicaid
$270,000
Spent on own lobbying
HR 2666/S 4204 - Medicaid Value-Based Payments for Patients (MVP) Act S 891 - Inclusion of Accelerating Kids' Access to Care Act & Give Kids a Chance Act 2025
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing